Primary ESRD Modality in New ESRD Patients,

100 New Patients (%) 1995-97*

84.3
80

60

40

20
8.7
3.1 3.7
0.2
0
Hemo CAPD CCPD IPD Transplant
IV -1
*Reported on HCFA Medical Evidence Form USRDS 1999
 Demographic Characteristics of New ESRD
Patients, 1997*
New Patients (Age or %)
80
61.1
60 53.1
44.4
40

20

0
Average Age % Male % Diabetes**
*Reported on HCFA Medical Evidence Form IV -2
**Primary/contributing cause of ESRD USRDS 1999
 Reported Race and Hispanic Ethnicity
among New ESRD Patients, 1997*
80 New Patients (%)
Number of People
3000
63.5 Hispanic = 10.9%
Counts of races 2189
60 overall
2000 included in "Other"
category
1000
40 515
182
28.7
0
Middle Indian Other/
20 East Subcontinent Multicultural

2.9 3.8
1.1
0
White Black Asian / Native American / Other
Pacific Islander Alaskan Native
*Reported on HCFA Medical Evidence Form
Unknown race is not included in percentages. IV -3
Approximately 0.6% of patients reported race as “Unknown”. USRDS 1999
 Primary Detailed Disease Groups Reported
among New ESRD Patients, 1997*
60 New Patients (%)

44.4

40

26.6

20
9.9
7.6
2.3 3.9 3.3 2.0
0 Diabetes Hyper- Glomerulo- Secondary Interstitial Cystic/ Neoplasms/ Miscel-
tension nephritis GN/ Vascu- Nephritis Hereditary/ Tumors laneous
litis Pyelo- Congenital
IV - 4
*Reported on HCFA Medical Evidence Form Nephritis
USRDS 1999
 Primary Disease Reported among New ESRD
Patients by Year, 1995-97*
New Patients (%)
50
44.4
43.3
42.3
1995 1996 1997
40

30 26.6
25.8 26.0

20 17.917.316.8

11.310.8
9.9
10
2.7 2.5 2.4
0
Diabetes Hypertension Glomerulo- Cystic Other Causes
nephritis Kidney
Disease IV -5
*Reported on HCFA Medical Evidence Form USRDS 1999
 Cardiovascular Patient Characteristics
among New Dialysis Patients, 1997*
New Patients (%)
40
34.7

30
25.1

20 15.6

9.4 9.7
10
0.9
0
Congestive CAD MI Cardiac CVD / Peripheral
Heart Arrest CVA/ Vascular
Failure TIA Disease
IV -6
*Reported on HCFA Medical Evidence Form USRDS 1999
 Ischemic Heart Disease (CAD) and Myocardial
Infarction (MI) by Gender and Diabetes in New
Dialysis Patients, 1997*
40 New Patients (%)
CAD MI
29.5
30 27.0
22.9
21.5
20

10.6 10.7
10 8.1 8.4

0
Male Female Yes No
Gender Diabetes
IV -7
*Reported on HCFA Medical Evidence Form USRDS 1999
 Ischemic Heart Disease (CAD) and Myocardial
Infarction (MI) by Age for New Dialysis Patients, 1997*
New Patients (%)
40
35.6
CAD MI
32.8

30

20.6
20
12.2 12.8

10 8.1
4.6
2.0
0
20-44 45-64 65-74 75+
*Reported on HCFA Medical Evidence Form
Age IV -8
USRDS 1999
 Ischemic Heart Disease (CAD) and Myocardial
Infarction (MI) by Race and Hispanic Ethnicity in
New Dialysis Patients, 1997*
35 New Patients (%)
30.6 CAD MI
30
25.7
25 22.0
19.5 20.2
20 17.6
14.8
15
11.8
9.3 9.8
10
5.1 5.6 5.9 6.0
5
0
White Black Asian Native Other Hispanic Non-
American Hispanic
IV -9
*Reported on HCFA Medical Evidence Form USRDS 1999
 Non-Cardiovascular Patient Characteristics
among New Dialysis Patients, 1997*
New Patients (%)
30
24.1

20

10 7.4
5.2 5.5 4.6
1.7
0 Diabetes COPD Cancer Smoker Inability to Inability to

on insulin Ambulate Transfer

IV -10
*Reported on HCFA Medical Evidence Form USRDS 1999
 Serum Albumin and Body Mass Index (BMI)
for New ESRD Patients, 1995-98*
Average Serum Albumin (g/dl) Average BMI (kg/m2)
3.5 27

3.4
26.05
26
3.3 25.52
25.67
3.25 25.39
3.22
3.20 3.19
3.2
25
3.1

3.0 24
1995 1996 1997 1998 1995 1996 1997 1998
IV -11
*Reported on HCFA Medical Evidence Form; 1998 data are through June USRDS 1999
 Distribution of Facilities by Average Number of
Comorbidities Reported per Patient, 1995-97*
60 Facilities (%) 55.6
50 N = 3,250 Facilities**

40
31.5
30

20

10 8.8
3.5
0.2 0.3 0.1
0
0 <1 1 to <2 2 to <3 3 to <4 4 to <5 5 to <6
Average Number of Comorbidities Reported
*Reported on HCFA Medical Evidence Form IV -12
**Excludes facilities with < 5 new patients in 3 years USRDS 1999
 Distribution of Facilities by Percent of Patients
with Zero Comorbidities Reported, 1995-97*
Facilities (%)
40
33.0
N = 3,250 Facilities**
30 27.2

20 18.7

10 7.3
5.7
1.9 2.8 1.5 0.4 0.7 0.6 0.2
0
0 0+ to 10+ to 20+ to 30+ to 40+ to 50+ to 60+ to 70+ to 80+ to 90+ to 100%
10% 20% 30% 40% 50% 60% 70% 80% 90% < 100%

Percent of Patients with Zero Comorbidities Reported

IV -13
*Reported on HCFA Medical Evidence Form
USRDS 1999
**Excludes facilities with < 5 new patients in 3 years
 Serum Creatinine and GFR
for New ESRD Patients by Age Group, 1995-97*
15 Average Serum Creatinine (mg/dl) Average GFR (ml/min)**
15

10.8
10 8.7 10
7.7 8.0
7.5 7.0 7.1
6.6

5 5

0 0
20-44 45-64 65-74 75+ 20-44 45-64 65-74 75+
Age Age
*Reported on HCFA Medical Evidence Form IV -14
**MDRD Formula USRDS 1999
 Serum Creatinine and Weight
for New ESRD Patients by Year, 1995-98*
10 Average Serum Creatinine (mg/dl) Average Weight (kg) 80

72.1 73.0
71.3 71.8
9 8.7
8.5 70
8.1 8.0
8

60
7

6 50
1995 1996 1997 1998 1995 1996 1997 1998
IV -15
*Reported on HCFA Medical Evidence Form; 1998 data are through June USRDS 1999
 EPO Use Before ESRD by Age and Gender
for New ESRD Patients, 1995-97*
Receiving EPO Before ESRD (%)
40

30 26.0
23.8 24.6 23.9
22.9 22.5
20

10

0
20-44 45-64 65-74 75+ Female Male
Age Gender IV -16
*Reported on HCFA Medical Evidence Form USRDS 1999
 EPO Use Before ESRD for New ESRD Patients
by Race and Hispanic Ethnicity, 1995-97*
Receiving EPO Before ESRD (%)
40

30.1
30 26.1
24.4
21.0 21.7 21.6
19.9
20

10

0
White Black Asian Native Other Hispanic Non-
American Hispanic
IV -17
*Reported on HCFA Medical Evidence Form USRDS 1999
 Prior vs. Current Employment among New
ESRD Patients, Ages 20-64, 1997*
New Patients (%)
36
32 32
30 6 months before ESRD (missing = 10%)
30 27 27 At onset of ESRD (missing = 4%)

24
20
18

12
6 7 6 6
6 5
1 1 0.5
0
Employed** Unemployed Retired, Retired Homemaker Medical Student
Disabled by Age Leave
*Reported on HCFA Medical Evidence Form. IV -18
**Includes part-time and full-time. Patients with employment status missing are excluded. USRDS 1999